ERBB2 and breast cancer: We summarized essential characteristics of breast cancer patients with tumor size ≤ 2 cm in the training cohort by distant metastasis-free survival (DMFS) time, age, tumor grade, lymph node status, biomarker status (ER, PR, and HER2), and the Prediction Analysis of Microarray 50 (PAM50) results (Table 1).